Sarepta Therapeutics, Inc 10-Q for FY2026 Q1
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2026-05-06
For: 2026-03-31
View Original
Added on
May 06, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on May 6, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).
Headline figures
Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $730.8M
- down 1.9% from $744.86M a year earlier
- Net income
- $330.96M
- compared with a net loss of $447.51M a year earlier
- Diluted EPS
- $2.88
- compared with -$4.60 a year earlier